United States · FDA National Drug Code directory
Carbidopa, Levodopa and Entacapone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-494_ab41796a-b051-41fa-b8ee-e88b9236931a
- Product NDC
- 33342-494
- Form
- TABLET, FILM COATED
- Composition / generic term
- Carbidopa, Levodopa and Entacapone
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250415
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBIDOPA — 31.25 mg/1
- LEVODOPA — 125 mg/1
- ENTACAPONE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (33342-494-11) · 33342-494-11
- 10 BLISTER PACK in 1 CARTON (33342-494-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 33342-494-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →